Oncorus

Developer of immunotherapy platform of oncolytic viruses for cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups85 employees language oncorus.com

Registered entities

Innovation

16 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,235 times.

YearFilings
20171
20182
20195
20207
202111
20228
202312
20243

Investor mix

19 investors on record; lead investors include UBS, Cowen, Perceptive Advisors; 1 has since exited.

Investor typeCountShare
Venture capital737%
Private equity15%
Bank & private debt421%
Other / undisclosed737%
Coming soon